PTC Therapeutics PTCT Q1 2025 earnings
Reported May 6, 2025 · After market close
Revenue$1.2BBeat by $803.5M
EPS$10.04Beat by $11.12
Revenue estimate$372.6M
EPS estimate-$1.08
Next report
Jul 30, 2026 (Today)Revenue estimate$298.6M
EPS estimate$0.24
Financials
Q1 2025Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
Ask the moment PTC Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did PTC Therapeutics report Q1 2025 earnings?
- PTC Therapeutics (PTCT) reported Q1 2025 earnings on May 6, 2025 after market close.
- What were PTC Therapeutics's Q1 2025 revenue and EPS?
- PTC Therapeutics reported revenue of $1.2B and eps of $10.04 for Q1 2025.
- Did PTC Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $372.6M by $803.5M. EPS beat the consensus estimate of $-1.08 by $11.12.
- How did PTC Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 459.7% from $210.1M a year earlier.
- Where can I find PTC Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001070081-25-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.